New hope for prostate cancer: adding local treatment to drug therapy may delay progression
NCT ID NCT05649943
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times
Summary
This study is for men with metastatic hormone-sensitive prostate cancer that has spread to a limited number of sites. It compares standard drug therapy (apalutamide plus hormone therapy) to the same drugs plus a local treatment like radiation or surgery to the prostate. The goal is to see if the combined approach delays cancer growth and reduces complications. About 566 participants will be enrolled across Italy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Santi Paolo e Carlo
NOT_YET_RECRUITINGMilan, Lombardy, 20153, Italy
Contact Email: •••••@•••••
Contact
-
European Institute of Oncology
NOT_YET_RECRUITINGMilan, Lombardy, 20141, Italy
Contact Email: •••••@•••••
Contact
-
Istituto Tumori Milano
RECRUITINGMilan, Mi, 20156, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.